CSNK1G3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.558600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.205200E-01
Normal-vs-Stage2
8.733200E-01
Normal-vs-Stage3
4.113600E-01
Normal-vs-Stage4
2.658200E-01
Stage1-vs-Stage2
8.251800E-01
Stage1-vs-Stage3
1.926050E-01
Stage1-vs-Stage4
2.861400E-01
Stage2-vs-Stage3
2.929200E-01
Stage2-vs-Stage4
1.959820E-01
Stage3-vs-Stage4
6.484500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.620400E-01
Normal-vs-AfricanAmerican
5.242200E-01
Normal-vs-Asian
4.467400E-01
Caucasian-vs-AfricanAmerican
1.875770E-01
Caucasian-vs-Asian
1.070220E-01
AfricanAmerican-vs-Asian
8.387800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.940200E-01
Normal-vs-Female
9.417400E-01
Male-vs-Female
3.748400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.438200E-01
Normal-vs-Age(41-60Yrs)
4.721200E-01
Normal-vs-Age(61-80Yrs)
9.617000E-01
Normal-vs-Age(81-100Yrs)
7.662000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.331800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.864400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.267000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.563200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.980400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.129600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.370400E-01
Normal-vs-Daily Drinker
8.057800E-01
Normal-vs-Weekly Drinker
5.941400E-01
Normal-vs-Occasional Drinker
4.066600E-01
Normal-vs-Social Drinker
7.373200E-01
Non Drinker-vs-Daily Drinker
9.831800E-01
Non Drinker-vs-Weekly Drinker
5.494600E-01
Non Drinker-vs-Occasional Drinker
2.250100E-02
Non Drinker-vs-Social Drinker
1.845400E-01
Daily Drinker-vs-Weekly Drinker
6.218800E-01
Daily Drinker-vs-Occasional Drinker
3.672000E-02
Daily Drinker-vs-Social Drinker
2.916000E-01
Weekly Drinker-vs-Occasional Drinker
2.412400E-02
Weekly Drinker-vs-Social Drinker
1.610380E-01
Occasional Drinker-vs-Social Drinker
3.359600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.941900E-02
Normal-vs-Grade 2
1.255330E-03
Normal-vs-Grade 3
3.477200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.891600E-01
Grade 1-vs-Grade 3
3.019600E-01
Grade 1-vs-Grade 4
4.941900E-02
Grade 2-vs-Grade 3
7.630200E-01
Grade 2-vs-Grade 4
1.255330E-03
Grade 3-vs-Grade 4
3.477200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.547000E-01
Normal-vs-NonDiabetic
9.692600E-01
Diabetic-vs-NonDiabetic
9.433400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.006800E-01
Normal-vs-NoPancreatitis
9.053000E-01
Pancreatitis-vs-NoPancreatitis
3.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.038600E-01
Normal-vs-N1
8.748600E-01
N0-vs-N1
6.566200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.937200E-01
Normal-vs-TP53-NonMutant
8.842200E-01
TP53-Mutant-vs-TP53-NonMutant
3.840800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
